1 Ward, A. S., "Variations in cocaine self-administration by inbred rat strains under a progressive-ratio schedule" 127 : 204-212, 1996
2 Janowsky, A., "Uptake and release of neurotransmitters" (Chapter 7) : Unit7.9-, 2001
3 Whittaker, V. P., "The separation of synaptic vesicles from nerve-ending particles (‘synaptosomes’)" 90 : 293-303, 1964
4 Heal, D. J., "The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety" 57 : 608-618, 2009
5 Whittaker, V. P., "The application of subcellular fractionation techniques to the study of brain function" 15 : 39-96, 1965
6 Ivannikov, M. V., "Synaptic vesicle exocytosis in hippocampal synaptosomes correlates directly with total mitochondrial volume" 49 : 223-230, 2013
7 Laruelle, M., "SPECT imaging of striatal dopamine release after amphetamine challenge" 36 : 1182-1190, 1995
8 Taylor, C. Z., "Religious addiction: obsession with spirituality" 50 : 291-315, 2002
9 Nagy, A., "Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient material (Percoll)" 43 : 1114-1123, 1984
10 Meyer, J. S., "Psychopharmacology: Drugs the Brain, and Behavior" 150-, 2013
1 Ward, A. S., "Variations in cocaine self-administration by inbred rat strains under a progressive-ratio schedule" 127 : 204-212, 1996
2 Janowsky, A., "Uptake and release of neurotransmitters" (Chapter 7) : Unit7.9-, 2001
3 Whittaker, V. P., "The separation of synaptic vesicles from nerve-ending particles (‘synaptosomes’)" 90 : 293-303, 1964
4 Heal, D. J., "The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety" 57 : 608-618, 2009
5 Whittaker, V. P., "The application of subcellular fractionation techniques to the study of brain function" 15 : 39-96, 1965
6 Ivannikov, M. V., "Synaptic vesicle exocytosis in hippocampal synaptosomes correlates directly with total mitochondrial volume" 49 : 223-230, 2013
7 Laruelle, M., "SPECT imaging of striatal dopamine release after amphetamine challenge" 36 : 1182-1190, 1995
8 Taylor, C. Z., "Religious addiction: obsession with spirituality" 50 : 291-315, 2002
9 Nagy, A., "Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient material (Percoll)" 43 : 1114-1123, 1984
10 Meyer, J. S., "Psychopharmacology: Drugs the Brain, and Behavior" 150-, 2013
11 Gonatas, N. K., "Morphological and biochemical changes in rat synaptosome fractions during neonatal development" 51 : 484-498, 1971
12 Heal, D. J., "Methylphenidate and its isomers" 20 : 713-738, 2006
13 Bozarth, M. A., "Methods of Assessing the Reinforcing Properties of Abused Drugs" Springer 241-273, 1987
14 Kamat, P. K., "Method and validation of synaptosomal preparation for isolation of synaptic membrane proteins from rat brain" 1 : 102-107, 2014
15 Sherman, A. D., "Isolation of metabolically distinct synaptosomes on Percoll gradients" 14 : 97-101, 1989
16 Mantle, T. J., "Inhibition of monoamine oxidase by amphetamine and related compounds" 25 : 2073-2077, 1976
17 Narita, M., "Implications of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats" 127 : 941-948, 2004
18 National Research Center, "Guide for the Care and Use of Laboratory Animals" National Academy of Sciences 2001
19 Abekawa, T., "Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens" 643 : 276-281, 1994
20 Koob, G. F., "Drugs of abuse: anatomy, pharmacology and function of reward pathways" 13 : 177-184, 1992
21 Mucha, R. F., "Drug reinforcement studied by the use of place conditioning in rat" 243 : 91-105, 1982
22 Koob, G. F., "Drug addiction: the yin and yang of hedonic homeostasis" 16 : 893-896, 1996
23 Wislet-Gendebien, S., "Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors" 9 : 92-, 2008
24 Rowley, H. L., "Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats" 28 : 254-269, 2014
25 Nestler, E. J., "Cellular basis of memory for addiction" 15 : 431-443, 2013
26 Hurd, Y. L., "Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission" 166 : 261-269, 1989
27 Drevets, W. C., "Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria" 49 : 81-96, 2001
28 Gorelick, D. A., "Agents in development for the management of cocaine abuse" 64 : 1547-1573, 2004
29 Jasinski, D. R., "Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse" 23 : 419-427, 2009
30 Pennick, M., "Absorption of lisdexamfetaminedimesylate and its enzymatic conversion to d-amphetamine" 6 : 317-327, 2010
31 Heal, D. J., "A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to D-amfetamine, methylphenidate and modafinil" 73 : 348-358, 2013
32 McKenna, D. J., "3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine" 38 : 505-512, 1991